SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-51555"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-51555" > Polymorphisms in NA...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003192naa a2200421 4500
001oai:DiVA.org:uu-51555
003SwePub
008080118s1999 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-515552 URI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Wadelius, Miau Uppsala universitet,Klinisk farmakogenomik och osteoporos4 aut0 (Swepub:uu)miawadel
2451 0a Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer
264 1c 1999
338 a print2 rdacarrier
520 a The development of prostate cancer is dependent on heredity, androgenic influences, and exposure to environmental agents. A high intake of dietary fat is associated with an increased risk of prostate cancer, either through influence on steroid hormone profiles or through production of carcinogenic compounds that require biotransformation by enzymes. The polymorphic glutathione S-transferase (GST), N-acetyltransferase (NAT), and cytochrome P450 (CYP) enzymes are of particular interest in prostate cancer susceptibility because of their ability to metabolize both endogenous and exogenous compounds, including dietary constituents. Association between different NAT2, CYP2D6, CYP2C19 and GSTP1 genotypes and prostate cancer was studied in a Swedish and Danish case-control study comprising 850 individuals. The combined Swedish and Danish study population was analysed by polymerase chain reaction for the NAT2 alleles *4, *5A, *5B, *5C, *6 and *7, and for the CYP2D6 alleles *l, *3 and *4. The Swedish subjects were also analysed for the CYP2C19 alleles *1 and *2, and the GSTP1 alleles *A, *B and *C. No association was found between prostate cancer and polymorphisms in NAT2, CYP2D6, CYP2C19 or GSTP1. An association between CYP2D6 poor metabolism and prostate cancer was seen among smoking Danes; odds ratio 3.10 (95% confidence interval 1.07; 8.93), P = 0.03, but not among smoking Swedes; odds ratio 1.19 (95% confidence interval 0.41; 3.42), P = 0.75. Smoking is not a known risk factor for prostate cancer, and the association between CYP2D6 poor metabolism and prostate cancer in Danish smokers may have arisen by chance.
653 a Prostate cancer
653 a NAT2
653 a CYP2D6
653 a CYP2C19
653 a GSTP1
653 a genotyping
653 a MEDICINE
653 a MEDICIN
700a Autrup, J.L.4 aut
700a Stubbins, M.J.4 aut
700a Andersson, S.O.4 aut
700a Johansson, J.E.4 aut
700a Wadelius, Claesu Uppsala universitet,Institutionen för genetik och patologi,Systems genomics4 aut0 (Swepub:uu)claeswad
700a Wolf, C.R.4 aut
700a Autrup, H.4 aut
700a Rane, A.u Uppsala universitet,Institutionen för medicinska vetenskaper,Klinisk farmakologi, A Rane4 aut
710a Uppsala universitetb Klinisk farmakogenomik och osteoporos4 org
773t Pharmacogeneticsg 9:3, s. 333-40q 9:3<333-40x 0960-314Xx 1473-561X
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-51555

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy